Acedapsone
Antimicrobial drug
From Wikipedia, the free encyclopedia
Acedapsone (INN) is an antimicrobial drug, which also has antimalarial activity.
| Clinical data | |
|---|---|
| Trade names | Rodilone Hansolar |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.936 |
| Chemical and physical data | |
| Formula | C16H16N2O4S |
| Molar mass | 332.37 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 290 °C (554 °F) |
| |
| |
| | |
Acedapsone is the INN for diacetyldapsone. It was synthesized and developed in 1937 by Ernest Fourneau and his team in the pharmaceutical chemistry laboratory of Pasteur Institute,[1] and it was marketed as Rodilone by the Rhône-Poulenc company.[2]
It is a long-acting prodrug of dapsone. It is used for treating leprosy.[3]
It crystallises as pale yellow needles from diethyl ether, and as leaflets from dilute ethanol. It is slightly soluble in water.[citation needed]
